Par Drugs and Chemicals Limited Share Price

Equities

PAR

INE04LG01015

Pharmaceuticals

Delayed NSE India S.E. 05:12:31 30/04/2024 pm IST 5-day change 1st Jan Change
269.5 INR -0.57% Intraday chart for Par Drugs and Chemicals Limited -5.50% +24.94%
Sales 2022 751M 9M Sales 2023 957M 11.47M Capitalization 1.72B 20.64M
Net income 2022 92M 1.1M Net income 2023 113M 1.35M EV / Sales 2022 2.4 x
Net cash position 2022 162M 1.94M Net cash position 2023 222M 2.67M EV / Sales 2023 1.57 x
P/E ratio 2022
21.3 x
P/E ratio 2023
15.2 x
Employees 105
Yield 2022
0.78%
Yield 2023
-
Free-Float 99%
More Fundamentals * Assessed data
Dynamic Chart
Par Drugs and Chemicals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Par Drugs and Chemicals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Par Drugs and Chemicals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Par Drugs and Chemicals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023 CI
Par Drugs and Chemicals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Par Drugs and Chemicals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Par Drugs and Chemicals Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
1,232,000 Equity Shares of Par Drugs and Chemicals Limited are subject to a Lock-Up Agreement Ending on 16-MAY-2022. CI
Par Drugs and Chemicals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022 CI
Par Drugs and Chemicals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
Par Drugs and Chemicals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021 CI
Par Drugs and Chemicals Limited Reports Earnings Results for the Full Year Ended March 31, 2021 CI
Par Drugs and Chemicals Limited Reports Earnings Results for the Second Quarter Ended September 30, 2020 CI
Par Drugs and Chemicals Limited Reports Earnings Results for the Full Year Ended March 31, 2020 CI
Par Drugs and Chemicals Limited Recommends Final Dividend for the Financial Year 2019-20 CI
More news
1 day-0.57%
1 week-5.50%
Current month+25.09%
1 month+25.09%
3 months+30.70%
6 months+32.43%
Current year+24.94%
More quotes
1 week
263.00
Extreme 263
290.90
1 month
215.00
Extreme 215
325.00
Current year
190.15
Extreme 190.15
325.00
1 year
161.60
Extreme 161.6
325.00
3 years
58.45
Extreme 58.45
325.00
5 years
13.10
Extreme 13.1
325.00
10 years
13.10
Extreme 13.1
325.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 46 26/99/26
Chief Executive Officer 49 26/99/26
Director of Finance/CFO 42 26/18/26
Members of the board TitleAgeSince
Chief Executive Officer 49 26/99/26
Director/Board Member 52 17/19/17
Director/Board Member 44 17/19/17
More insiders
Date Price Change Volume
30/24/30 269.5 -0.57% 31,981
29/24/29 271 +2.32% 53,859
26/24/26 264.9 -4.06% 49,903
25/24/25 276.1 -1.90% 40,862
24/24/24 281.4 -1.07% 38,834

Delayed Quote NSE India S.E., April 30, 2024 at 05:12 pm IST

More quotes
Par Drugs and Chemicals Limited is an India-based company engaged in manufacturing of active pharma ingredients (APIs) and fine chemicals for the domestic market as well as for exports to international markets. The Company manufactures a diverse range of antacid molecules. The Company’s products include magnesium hydroxide, magnesium trisilicate, magnesium carbonate, light magnesium oxide, magnesium oxide heavy, magnesium oxide USP, dried aluminum hydroxide gel, magaldrate, magnesium aluminum silicate hydrated, alma gate, hydrotalcite, aluminum hydroxide magnesium carbonate co-dried gel, aluminum-magnesium silicate BP, sodium aluminum silicate, precipitated silica, magnesium silicate, amorphous, colloidal silicon dioxide, and sucralfate USP. The Company owns and operates its manufacturing facilities at Bhavnagar in Gujarat. It has over four manufacturing blocks at Bhavnagar, which are for different products, having a capacity of approximately 9,700 metric tons per annum.
More about the company